Day 1 - Thursday, 19 September 2019

 08:45 AMOpening of the workshop 
 Session 1: Epidemiology of HIV and hepatitis in the CEE countries and access to care
Chair: T.b.c.
 09:00 AMEpidemiology of viral hepatitis infection and treatment in Europe
 9:30 AM

Epidemiology of HIV infection and treatment in Europe
Teymur Noori, ECDC, Stockholm, Sweden

 10:00 AMWhere we are in terms of providing access and where we should go
 10:30 AMCoffee break and poster viewing 
 Session 2: Access to care
Chair: T.b.c.
 11:00 AM

EECA: are we lagging behind?  
Sergey Golovin, ITPCru, St. Petersburg, Russia

 11:10 AM

Access to quality assured  (WHO prequalified) generic medicines in the region
Liudmyla Maistat, Medicines Patent Pool, Geneva, Switzerland

 11:20 AMAccess to key populations 
 11:30 AMRoundtable discussion 
 Session 3: HIV and hepatitis coinfection
Chair: T.b.c.
 11:45 AM

Management of HIV/HCV in young women
Vadim Rassokhin, MD, 1st St. Petersburg State Medical University "Acad. I.P. Pavlov", St. Petersburg, Russia

  Abstract-driven presentations 
 12:00 PM2 slots for abstract-driven presentations 
 12:20 PMDiscussion 
 12:30 PMGroup picture and lunch 
 1:30 PMSpecial session 
 Session 4: PrEP
Chair: T.b.c.
 2:30 PM

PrEP and STI testing in CEE: What are the barriers, what works?
Milosz Parczewski, MD, PhD, Pomeranian Medical University, Sczecin, Poland

  Abstract-driven presentations 
 2:50 PM3 slots for abstract-driven presentations 
 3:20 PMPanel discussion 
 3:35 PMCoffee break and poster viewing 
 Session 5: Linkage to care and management of treatment failure in HIV
Chair: T.b.c.
 4:05 PM

Switching to second line HIV therapy
Pavel Khaykin, MD, MainFachArzt, Frankfurt, Germany

 4:35 PMRaben, DortheIntegrated testing for HIV, hepatitis and STIs
Dorthe Raben
CHIP, Copenhagen, Denmark
  Abstract-driven presentations 
 5:05 PM2 slots for abstract-driven presentations 
 5:25 PMPanel discussion 
 5:30 PMIndustry-sponsored symposium 
 6:30 PMEnd of day 1
Welcome reception and poster viewing
 7:00 PMWorkshop dinner

Day 2 - Friday, 20 September 2019

 8:30 AMIndustry-sponsored symposium 
 Session 6: HIV and Tuberculosis coinfection
Chair: T.b.c.
 9:30 AMManagement TB  and HIV infection
Daria Podlekareva 
University of Copenhagen, Copenhagen, Denmark
 10:00 AM

The challenging TB case: clinical, virological and pharmacological considerations
Jonathan Schapiro, MD, Sheba Medical Centre, Tel Aviv, Israel

  Abstract-driven presentations 
 10:30 PM2 slots for abstract-driven presentations 
 10:50 AMDiscussion 
 11:00 AMCoffee break and poster viewing 
 11:30 AMIndustry-sponsored symposium 
 12:30 PMLunch 
 Session 7: Hot topics in HIV and Hepatitis
Chair:  T.b.c.
 1:30 PMVaccinations for HIV patients: which vaccinations when and how?
Carolynne Schwarze-Zander 
University of Bonn, Bonn, Germany
 1:55 PM

Treatment of Hepatitis B: What are the remaining challenges?
Olga Golubovska, MD, PhD, Bogomolets National Medical University, Kiev, Ukraine

 2:20 PM

Ligita Jančorienė

HIV/HCV coinfection: Influence on risk for cancer and
cardiovascular events, and impact of successful HCV cure
Ligita Jancoriene, MD, PhD, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania

 2:45 PMHepatitis E in HIV-infected patients 
 3:10 PMEnd of conference